Dr Patrick Gerard Squires, OD | |
405 32nd St, Ste. 103, Bellingham, WA 98225-0951 | |
(360) 734-6464 | |
(360) 733-5585 |
Full Name | Dr Patrick Gerard Squires |
---|---|
Gender | Male |
Speciality | Optometrist |
Location | 405 32nd St, Bellingham, Washington |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114096146 | NPI | - | NPPES |
GAB16225 | Other | WA | MEDICARE GROUP # |
2015972 | Medicaid | WA | |
130706 | Other | WA | LABOR AND INDUSTRIES |
74309 | Other | WA | REGENCE BLUE SHIELD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | 3073TX (Washington) | Primary |
152WC0802X | Optometrist - Corneal And Contact Management | 3073TX (Washington) | Secondary |
Provider Name | Neighborcare Health |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1578593562 PECOS PAC ID: 0143134205 Enrollment ID: O20040128000573 |
News Archive
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced new study results that demonstrate hospitals could realize substantial savings by substituting Flexi-Seal FMS for traditional fecal management methods.
A new study published recently in ScienceDirect by researchers from Syracuse University and SUNY Upstate Medical University shows that people with intellectual and developmental disabilities living in residential group homes are more likely to be diagnosed with COVID-19 and die from the virus than those without IDD.
Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for the first quarter of Fiscal 2014 (ended September 30, 2013).
An investigational drug for the treatment of sickle cell disease is showing early promise in clinical trials for impacting biomarkers of the disease in patients, reported UConn School of Medicine researchers at the European Hematology Association Congress in Amsterdam this week.
University of Missouri engineers and their research collaborators at Nanova, Inc. are one step closer to a painless way to replace fillings. After favorable results in the lab, human clinical trials are underway on the "plasma brush."
› Verified 6 days ago
Provider Name | Binyon Vision Bellingham Pllc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1265107114 PECOS PAC ID: 3779980578 Enrollment ID: O20210921003189 |
News Archive
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced new study results that demonstrate hospitals could realize substantial savings by substituting Flexi-Seal FMS for traditional fecal management methods.
A new study published recently in ScienceDirect by researchers from Syracuse University and SUNY Upstate Medical University shows that people with intellectual and developmental disabilities living in residential group homes are more likely to be diagnosed with COVID-19 and die from the virus than those without IDD.
Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for the first quarter of Fiscal 2014 (ended September 30, 2013).
An investigational drug for the treatment of sickle cell disease is showing early promise in clinical trials for impacting biomarkers of the disease in patients, reported UConn School of Medicine researchers at the European Hematology Association Congress in Amsterdam this week.
University of Missouri engineers and their research collaborators at Nanova, Inc. are one step closer to a painless way to replace fillings. After favorable results in the lab, human clinical trials are underway on the "plasma brush."
› Verified 6 days ago
Provider Name | Blue Wave Eye Doctors Professional Limited Liability Company |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1053060475 PECOS PAC ID: 5294116265 Enrollment ID: O20230104002260 |
News Archive
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced new study results that demonstrate hospitals could realize substantial savings by substituting Flexi-Seal FMS for traditional fecal management methods.
A new study published recently in ScienceDirect by researchers from Syracuse University and SUNY Upstate Medical University shows that people with intellectual and developmental disabilities living in residential group homes are more likely to be diagnosed with COVID-19 and die from the virus than those without IDD.
Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for the first quarter of Fiscal 2014 (ended September 30, 2013).
An investigational drug for the treatment of sickle cell disease is showing early promise in clinical trials for impacting biomarkers of the disease in patients, reported UConn School of Medicine researchers at the European Hematology Association Congress in Amsterdam this week.
University of Missouri engineers and their research collaborators at Nanova, Inc. are one step closer to a painless way to replace fillings. After favorable results in the lab, human clinical trials are underway on the "plasma brush."
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Patrick Gerard Squires, OD Po Box 29317, Bellingham, WA 98228-1317 Ph: () - | Dr Patrick Gerard Squires, OD 405 32nd St, Ste. 103, Bellingham, WA 98225-0951 Ph: (360) 734-6464 |
News Archive
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced new study results that demonstrate hospitals could realize substantial savings by substituting Flexi-Seal FMS for traditional fecal management methods.
A new study published recently in ScienceDirect by researchers from Syracuse University and SUNY Upstate Medical University shows that people with intellectual and developmental disabilities living in residential group homes are more likely to be diagnosed with COVID-19 and die from the virus than those without IDD.
Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for the first quarter of Fiscal 2014 (ended September 30, 2013).
An investigational drug for the treatment of sickle cell disease is showing early promise in clinical trials for impacting biomarkers of the disease in patients, reported UConn School of Medicine researchers at the European Hematology Association Congress in Amsterdam this week.
University of Missouri engineers and their research collaborators at Nanova, Inc. are one step closer to a painless way to replace fillings. After favorable results in the lab, human clinical trials are underway on the "plasma brush."
› Verified 6 days ago
Dr. Rajbir Kaur Khehra, Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4540 Cordata Pkwy Ste 103, Bellingham, WA 98226 Phone: 360-676-8663 Fax: 360-676-8682 | |
Bryan T Redick, OD Optometrist Medicare: Medicare Enrolled Practice Location: 302 36th St, Bellingham, WA 98225 Phone: 360-363-0360 Fax: 360-363-0160 | |
Aleksey Shkurat Od Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 1303 Cornwall Ave, Bellingham, WA 98225 Phone: 360-647-0421 Fax: 360-647-0469 | |
Dr. Cam My Ly, OD Optometrist Medicare: Medicare Enrolled Practice Location: 4125 Arctic Ave, Bellingham, WA 98226 Phone: 360-812-7015 Fax: 360-812-7019 | |
Vision Plus Optometrist Medicare: Medicare Enrolled Practice Location: 2520 James St, Bellingham, WA 98225 Phone: 360-733-7393 Fax: 360-722-7785 | |
Dr. Hannah Margaret Joyner, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 720 Birchwood Ave, Bellingham, WA 98225 Phone: 360-733-1720 Fax: 360-733-0109 | |
Rhonda Swanson, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4420 Meridian St, Kulshan Eye Care, Bellingham, WA 98226 Phone: 360-647-0212 Fax: 360-647-2212 |